SCHEMBL6786229

SCHEMBL6786229

COc1ccccc1Cc1ccc2[nH]c3cnn(C)c3c(=O)c2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.42
HSD17B10 Q99714 2/20 0.42
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
GLA P06280 1/20 0.42
GAA P10253 1/20 0.42
HPGD P15428 1/20 0.42
CASP1 P29466 1/20 0.42
HTT P42858 1/20 0.42
CASP7 P55210 1/20 0.42
AR P10275 1/20 0.41
PRNP P04156 2/20 0.39
RXFP1 Q9HBX9 1/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
CHEK2 O96017 1/20 0.38
PDE10A Q9Y233 1/20 0.38
CTSV O60911 2/20 0.38
CTSL P07711 2/20 0.38
TP53 P04637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6784689 0.85 PRMT5 (0.37) KDM4EARMEN1KMT2ATP53
SCHEMBL6791754 0.85 BPTF (0.35) MEN1KMT2APOLB
SCHEMBL6788322 0.85 AR (0.37) KDM4EALDH1A1HPGDHTTAR
SCHEMBL6786192 0.85 KEAP1 (0.36) KDM4EALDH1A1GAAMEN1KMT2A
Hydrochloric Acid SCHEMBL6782358 0.84 BPTF (0.35) MEN1KMT2APOLB
Hydrochloric Acid SCHEMBL6782998 0.84 AR (0.36) KDM4EALDH1A1HPGDHTTAR
SCHEMBL6783054 0.84 MAPK1 (0.32) KDM4EALDH1A1HPGDHTTMEN1
SCHEMBL6785795 0.83 GABRA1 (0.44) HSD17B10KDM4EALDH1A1CTSVCTSL
SCHEMBL6785194 0.83 HTR2A (0.37) CTSVCTSL
SCHEMBL6785560 0.83 ABCG2 (0.42) HSD17B10KDM4EALDH1A1GAAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6686373-B2 ANALGESICS; ANTIINFLAMMATORY AGENT WARNER-LAMBERT COMPANY LLC 2004-02-03 US disclosed
US-20030130277-A1 Pyrazoloquinolinone derivatives as protein kinase C inhibitors KAWAMURA KIYOSHI (JP) 2003-07-10 US disclosed
EP-1310498-A2 Pyrazoloquinolinone derivatives as protein kinase C inhibitors PFIZER INC. (US) 2003-05-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030130277-A1 Pyrazoloquinolinone derivatives as protein kinase C inhibitors PRKCB, PRKCA, PRKCG ATM 591/4885HSD17B10 3513/4885KDM4E 1349/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.